Equity Profile

CVS

CVS Health Corporation

Health CareHealth Care Services$135.1B

May6Wed

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:30 AM EDT

CVS Health Beats on EPS, Stock Up 7.65%

Metric	Actual	Expected	Surprise
EPS	$2.57	$2.21	+16.39%
Revenue	N/A	$95.0B	N/A

management commentary, guidance changes, and full analysis available with Pro.

CVS Health Beats on EPS, Stock Up 7.65%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$2.57	$2.21	+16.39%
Revenue	N/A	$95.0B	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

CVS Health's strong earnings per share performance exceeded expectations, contributing to a notable 7.65% increase in stock price. The company did not provide revenue figures or future guidance, leaving some uncertainty. Investors may view the EPS beat as a positive sign of operational efficiency or cost management.

Company Snapshot

CVS Health Corporation is a major player in the health care sector, providing a wide range of services including pharmacy benefits management, retail pharmacy, and health insurance. With a market cap of $105 billion, CVS is significant in shaping health care accessibility and affordability in the U.S.

Key Metrics to Watch

EPS

Earnings per share (EPS) is a crucial measure of profitability and indicates how much profit is attributed to each share of stock.

$2.21

Revenue

Total revenue reflects the company's overall sales performance and is essential for understanding growth trends.

$95.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q4 2025, CVS reported an EPS of $1.09, exceeding expectations by nearly 10%. However, the stock saw a slight decline the following day, indicating mixed market reactions.

Management Promises & Guidance

Focus on expanding digital health services.
Commitment to improving customer experience in retail locations.
Plans to enhance pharmacy benefit management offerings.

Expectations

Wall Street Expectations

Analysts expect CVS to report solid earnings this quarter, with a consensus EPS of $2.21. The market is closely watching how the company navigates ongoing challenges in the health care sector.

Bull Case

If CVS can exceed EPS expectations and show strong revenue growth, it may indicate robust demand for its services, leading to positive investor sentiment.

Bear Case

Conversely, if CVS fails to meet earnings expectations or provides weak guidance, it could raise concerns about its ability to compete in a challenging market.

Key Metrics to Watch

EPS

$2.21

Earnings per share (EPS) is a crucial measure of profitability and indicates how much profit is attributed to each share of stock.

Revenue

$95.0B

Total revenue reflects the company's overall sales performance and is essential for understanding growth trends.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will CVS achieve an EPS of at least $2.21 this quarter?

Meeting or exceeding this EPS target is crucial for maintaining investor confidence and could drive stock price appreciation.

What guidance will CVS provide for revenue growth in the upcoming quarters?

Clear guidance on revenue growth will help investors gauge the company's future performance and competitive positioning.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate CVS's ability to leverage its digital health initiatives, which could drive unexpected revenue growth.

Supporting Evidence

Recent investments in digital health services could yield higher-than-expected customer engagement.

The options market indicates a potential for greater volatility, suggesting that significant movements are anticipated.

Historically, CVS has consistently beaten EPS estimates, indicating a potential for another positive surprise.

Key Risk

If CVS's digital initiatives do not translate into tangible revenue growth, the current optimistic consensus could be challenged.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating CVS's ability to sustain growth amidst competitive pressures and changing health care dynamics.

Bull Confirmed If

Achieving an EPS of $2.21 or higher with revenue exceeding $95 billion would confirm the bull case.

Bear Confirmed If

An EPS below $2.10 or revenue under $91 billion would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±6.12%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a moderate move around the earnings report, suggesting that investors anticipate some volatility.

Options are pricing ±6.6% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

32.4%

Calls (708K)P/C Ratio: 0.83Puts (710K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests a potential stock increase of around 3.55%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 16.84%, reflecting market disappointment and concerns about future performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

Senate only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-ARJohn BoozmanSen.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on the performance of digital health services and their impact on overall revenue.
2Updates on customer engagement strategies in retail locations.
3Any commentary on competitive pressures in the pharmacy benefit management space.
4Guidance on revenue expectations for the next quarter.
5Insights into cost management strategies and their effect on margins.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share (EPS) is a crucial measure of profitability and indicates how much profit is attributed to each share of stock.

$2.21

Revenue

Total revenue reflects the company's overall sales performance and is essential for understanding growth trends.

$95.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q4 2025, CVS reported an EPS of $1.09, exceeding expectations by nearly 10%. However, the stock saw a slight decline the following day, indicating mixed market reactions.

Management Promises & Guidance

Focus on expanding digital health services.
Commitment to improving customer experience in retail locations.
Plans to enhance pharmacy benefit management offerings.

Expectations

Wall Street Expectations

Analysts expect CVS to report solid earnings this quarter, with a consensus EPS of $2.21. The market is closely watching how the company navigates ongoing challenges in the health care sector.

Bull Case

If CVS can exceed EPS expectations and show strong revenue growth, it may indicate robust demand for its services, leading to positive investor sentiment.

Bear Case

Conversely, if CVS fails to meet earnings expectations or provides weak guidance, it could raise concerns about its ability to compete in a challenging market.

Key Metrics to Watch

EPS

$2.21

Earnings per share (EPS) is a crucial measure of profitability and indicates how much profit is attributed to each share of stock.

Revenue

$95.0B

Total revenue reflects the company's overall sales performance and is essential for understanding growth trends.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will CVS achieve an EPS of at least $2.21 this quarter?

Meeting or exceeding this EPS target is crucial for maintaining investor confidence and could drive stock price appreciation.

What guidance will CVS provide for revenue growth in the upcoming quarters?

Clear guidance on revenue growth will help investors gauge the company's future performance and competitive positioning.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate CVS's ability to leverage its digital health initiatives, which could drive unexpected revenue growth.

Supporting Evidence

Recent investments in digital health services could yield higher-than-expected customer engagement.

The options market indicates a potential for greater volatility, suggesting that significant movements are anticipated.

Historically, CVS has consistently beaten EPS estimates, indicating a potential for another positive surprise.

Key Risk

If CVS's digital initiatives do not translate into tangible revenue growth, the current optimistic consensus could be challenged.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating CVS's ability to sustain growth amidst competitive pressures and changing health care dynamics.

Bull Confirmed If

Achieving an EPS of $2.21 or higher with revenue exceeding $95 billion would confirm the bull case.

Bear Confirmed If

An EPS below $2.10 or revenue under $91 billion would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±6.12%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a moderate move around the earnings report, suggesting that investors anticipate some volatility.

Options are pricing ±6.6% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

32.4%

Calls (708K)P/C Ratio: 0.83Puts (710K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests a potential stock increase of around 3.55%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 16.84%, reflecting market disappointment and concerns about future performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

Senate only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-ARJohn BoozmanSen.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on the performance of digital health services and their impact on overall revenue.
2Updates on customer engagement strategies in retail locations.
3Any commentary on competitive pressures in the pharmacy benefit management space.
4Guidance on revenue expectations for the next quarter.
5Insights into cost management strategies and their effect on margins.